NASDAQ$BLFS

BioLife Solutions Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

BioLife Solutions reported strong topline growth and improvements in gross margin and adjusted EBITDA.

BioLife Solutions reported a 115% increase in revenue to $36.2 million compared to Q1 2021, with organic revenue growth of 45%. The company affirms its 2022 revenue guidance of $159.5 million to $171.0 million.

  • Total revenue for the first quarter of 2022 was $36.2 million, an increase of 115% from $16.8 million for the first quarter of 2021, with organic revenue growth of 45%.
  • Gross margin (GAAP) for the first quarter of 2022 was 29% compared with 52% for the first quarter of 2021.
  • Operating loss (GAAP) for the first quarter of 2022 was $7.6 million compared with operating loss of $981,000 for the first quarter of 2021.
  • The company affirms 2022 revenue guidance of $159.5 million to $171.0 million, reflecting year-over-year growth of 34% to 44% and organic growth of 28% to 39%.

Headline financials

Total Revenue

$36.2M

Previous: $16.8M+115.0%
EPS (adj)

-$0.19

Previous: $0.01-2010.0%
GAAP gross margin

29.0%

Previous: 52.0%-44.2%
Non-GAAP adjusted gross margin

33.0%

Previous: 55.0%-40.0%
GAAP operating loss

-$7.6M

Previous: -$981K-674.7%
Adjusted EBITDA

-$814K

Previous: $2.8M-129.1%
Capital Expenditures

-$1.46M

Previous: -$1.72M+15.3%
Free Cash Flow

-$8.52M

Previous: -$2.84M-200.3%
Net Income

-$7.07M

Previous: -$1.12M-532.0%
Operating Income

-$7.63M

Previous: -$981K-678.1%
Gross Profit

$10.5M

Previous: $8.74M+20.2%
Cash & Equivalents

$59.5M

Previous: $89M-33.2%
Total Assets

$544M

Previous: $240M+126.6%
Stock-Based Comp

$5.4M

Previous: $1.51M+258.7%

Revenue & EPS history

BioLife · Revenue · Quarterly

$36.2M

Q1 2022+115%vs Q1 2021
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

BioLife · $14.9M total across 1 segment · Q1 2022

  • Cell Processing platform
    $14.9M

Forward guidance

Management is affirming 2022 revenue guidance, which is based on expectations for our existing business. Total revenue for 2022 is expected to range from $159.5 million to $171.0 million, reflecting year-over-year growth of 34% to 44% and organic growth of 28% to 39%. Although the company does not provide guidance below the revenue line, we expect positive 2022 full year adjusted EBITDA.

Tailwinds

  • Total revenue for 2022 is expected to range from $159.5 million to $171.0 million.
  • Cell Processing platform: $64.0 million to $67.5 million, an increase of 42% to 50% over 2021 and organic growth of 30% to 35%.
  • Freezers and Thaw Systems platform: $74.0 million to $77.5 million, an increase of 31% to 37% over 2021 and organic growth of 28% to 39%.
  • Total and organic revenue in a range of $21.5 million to $26.0 million, an increase of 22% to 48% over 2021 for Storage and Storage Services platform.
  • Expect positive 2022 full year adjusted EBITDA.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+4.3%

Avg return

30 days after

44%

22 / 50 earnings

Positive

+21.4%

Q3 2022

Best reaction

-34.5%

Q4 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.3%-2.4%+22.4%
Q4 2025+8.0%-8.1%-17.3%
Q3 2025-4.2%-4.1%-5.8%
Q2 2025+10.0%+24.4%+28.2%
Q1 2025+4.0%-1.4%+6.0%
Q4 2024+2.1%+7.6%-0.9%
Q3 2024-9.4%-21.0%+0.5%
Q2 2024+14.5%+20.3%+7.9%
Q1 2024+8.9%+25.0%+13.2%
Q4 2023+5.1%-0.5%+8.5%
Q3 2023-5.7%+3.1%+14.2%
Q2 2023-29.7%-34.9%-30.3%
Q1 2023-2.9%+3.5%+20.6%
Q4 2022+0.2%+2.7%-7.4%
Q3 2022+21.4%+14.1%-4.6%
Q2 2022+13.7%+15.7%+25.6%
Q1 2022-3.8%+1.6%+18.3%
Q4 2021-0.3%+0.9%-3.7%
Q3 2021-6.0%+5.2%-30.3%
Q2 2021-1.8%-3.9%+12.0%
Q1 2021-2.1%+4.8%+25.1%
Q4 2020+8.3%-7.8%-14.7%
Q3 2020+5.8%+0.8%+21.6%
Q2 2020+0.3%-5.4%+5.6%
Q1 2020+3.0%+10.5%+1.5%
Q4 2019-34.5%-36.7%-27.8%
Q3 2019-12.8%-8.8%-7.4%
Q2 2019-6.2%+1.1%+7.7%
Q1 2019-2.4%+4.5%+8.8%
Q4 2018+10.7%+19.4%+5.5%
Q3 2018+15.0%-8.0%-7.8%
Q2 2018-4.8%-1.0%+2.3%
Q1 2018-3.7%+7.6%+23.5%
Q4 2017-4.4%-10.2%+22.4%
Q3 2017+18.0%+21.6%+8.2%
Q2 2017+3.8%+8.2%+30.6%
Q1 2017+3.7%-1.4%+7.8%
Q4 2016-5.0%-9.5%-7.7%
Q3 2016+0.7%+2.7%+5.4%
Q2 2016-2.4%-7.7%-15.9%
Q3 2012+10.0%
Q1 2012+0.0%
Q4 2011+0.0%
Q3 2011+0.0%
Q2 2011-14.3%
Q1 2011+0.0%
Q4 2010-11.1%
Q3 2010+0.0%
Q2 2010+0.0%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro